1. Scrip
  2. >>R&D
  3. >>Clinical Trials

Moderna Marches First Coronavirus Vaccine To US Test

Enters Clinic In Just 42 days

 
• By Brian Yang

The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.

BEIJING STREETS REMAIN DESERTED FEB.23 AMID CORONAVIRUS OUTBREAK
BEIJING STREETS REMAIN DESERTED DESPITE OFFICES REOPENING • Source: Brian Yang

The first vaccine for the new coronavirus is officially out of lab and being put to the clinical test, as the outbreak originating from Wuhan in China continues its spread around the world with hundreds of new cases being reported in South Korea, Italy and Iran.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

AstraZeneca COPD Drug Breztri Breezes Through Asthma Trials

 
• By Kevin Grogan

The triple therapy improves lung function in the Phase III KALOS and LOGOS studies

DIA Korea: Medical Turmoil, Global Factors Blunt Korea’s Trial Edge

 
• By Jung Won Shin

DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.

Moderna Punts On US Vaccine Policy Changes, Will Focus More On Cancer

 
• By Joseph Haas

On its Q1 earnings call, Moderna avoided criticizing policy changes affecting vaccines but de-emphasized its flu/COVID-19 vaccine for under-50 and prioritized cancer programs.

GSK Talks Up Nucala COPD Hospitalization Data In Challenge To Dupixent

 
• By Kevin Grogan

As the PDUFA date for the UK major’s IL-5 inhibitor draws close.

More from R&D